Residency · Teaneck, NJ
Sponsored by Holy Name Medical Center
The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial.
Annals of oncology : official journal of the European Society for Medical Oncology · 2025 · 47 citations · Sharyn Lewin
Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer.
Future oncology (London, England) · 2024 · 23 citations · Sharyn Lewin